Dazodalibep, a CD40L Antagonist, in a Phase 2, Randomized, Double-Blind, Placebo-Controlled, Crossover Trial of Subjects with Sjogren's Disease Having Unacceptable Symptomatic Burden but Limited Extraglandular Organ Involvement
Dazodalibep
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Dazodalibep, a CD40L Antagonist, in a Phase 2, Randomized, Double-Blind, Placebo-Controlled, Crossover Trial of Subjects with Sjogren's Disease Having Unacceptable Symptomatic Burden but Limited Extraglandular Organ Involvement ### Output: Dazodalibep